Melasmahttps://en.wikipedia.org/wiki/Melasma
Melasma waa madoow ama maqaarka madaw ee wajiga Melasma waxaa loo maleynayaa inay ka timid soo-bandhigidda qorraxda, saadaalin hidde-side, isbeddel hormoon, iyo cuncun maqaarka. In kasta oo ay qof kasta saamayn karto, si gaar ah ayay ugu badan tahay haweenka, gaar ahaan haweenka uurka leh iyo kuwa qaata dawooyinka ka hortagga uurka ama hormoonnada beddelka daawooyinka.

Melasma laguma xallin karo daawaynta laysarka muddo cayiman, maadaama ay tahay cudur uu midabku si joogto ah u soo saaro. Tranxenemic acid waxay caawisaa inay hagaajiso si loo yareeyo midabaynta.

Daawaynta
Wadamada qaarkood (tusaale, Japan, Korea), tranexamic acid-ka afka laga qaato ayaa laga heli karaa miiska waana wax ku ool ah. Kareemka melasma ee leh tranexamic acid iyo azelaic acid ayaa laga yaabaa inay qayb ahaan waxtar leeyihiin.
Hydroquinone waxaa laga yaabaa in loo isticmaalo daawaynta hyperpigmentation, laakiin FDA waxay joojisay alaabada OTC ee ay ku jiraan hydroquinone ilaa 2020.
#Tranexamic acid [TRANSINO]

#Laser toning technique (low fluence QS1064 laser)
#Triluma
☆ Natiijooyinka Stiftung Warentest ee 2022 ee ka yimid Jarmalka, ku qanacsanaanta macaamilka ee ModelDerm ayaa waxyar uun ka hooseysay la-talinta telemedicine-ka ee lacagta lagu bixiyo.
  • Waa xaalad caadi ah oo lagu arko haweenka Aasiyaanka ah ee horraanta 40-ka. Nabarka goobaaban ee sawirka ayaa ku dhow lentigo halkii uu ka ahaan lahaa melasma.
    References Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review 28374042
    Tranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI after treat?ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.
     The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review 35888655 
    NIH
    Dhawaan, low-fluence Q-switched Nd:YAG (LFQSNY) laser ayaa caan ku noqday daawaynta melasma, gaar ahaan Aasiya. Soo koobida daraasado kala duwan ayaa ahaa mid adag, laakiin LFQSNY waxay u muuqataa guud ahaan waxtar iyo badbaado u leh melasma marka la barbar dhigo daawaynta dhaqameed. Si kastaba ha ahaatee, xaaladaha qaarkood ee hypopigmentation mottled ayaa lagu soo warramey inay tahay saameyn dhinaca LFQSNY, suurtogal ah inay sabab u tahay tamarta laser sare. Isticmaalka degdega ah ee LFQSNY waxay sidoo kale u horseedi kartaa midab ka soo baxa bararka, gaar ahaan midabada maqaarka ee madow.
    Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
     Pigmentation Disorders: Diagnosis and Management 29431372
    Dhibaatooyinka midabaynta ayaa inta badan laga helaa daryeelka aasaasiga ah. Noocyada caadiga ah ee xanuunka hyperpigmentation waxaa ka mid ah post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
    Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.